As VP of Customer Engagement at Cresen Solutions, Rob drives the business development and marketing efforts. He enjoys working with clients to seek out ways to improve their operational efficiencies to reduce risk. Rob has been working in the Life Sciences Compliance / Transparency space since 2008 when he helped launch one of the industry’s first aggregate spend reporting tools while working for Health Market Science. Since then he has been a business development leader in other companies in the Life Sciences space including Aileron Solutions, Indegene, R-Squared and Polaris.
By Robert Zelinsky on June 28, 2019
When one of the world’s largest life sciences companies is accused of bribery, misconduct, and corruption, everyone in the industry takes notice. Fresenius Medical, a multinational dialysis equipment provider, agreed to pay $231 million towards resolving alleged FCPA violations in March 2019 after an investigation by the U.S. Department of Justice (DOJ) and the Securities Exchange Commission (SEC).
Are you aware of any sales reps exceeding event spending caps? Do you have a firm grip on your company's expenditures for things like meals, travel, and consulting fees? Are you monitoring your company's relationships with higher risk partners like patient assistance program providers, patient advocacy groups, and managed care organizations?
